Markus Charles Paul Grompe MD
Professor, Pediatrics, Oregon Health and Science University School of
Join to view full profile
3181 Sw Sam Jackson Park RdPortland, OR 97239
Phone+1 503-494-5516
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Markus Grompe, MD is a pediatrician in Portland, Oregon. He is currently licensed to practice medicine in Oregon, Texas, and Washington. He is a Professor at Oregon Health and Science University School of.
Education & Training
Oregon Health & Science University (OHSU Health)Residency, Pediatrics, 1984 - 1987
University of Ulm Faculty of MedicineClass of 1983
Certifications & Licensure
OR State Medical License 1992 - 2027
TX State Medical License 1988 - 1992
WA State Medical License 1986 - 1989
American Board of Medical Genetics and Genomics Clinical Biochemical/Molecular Genetics- American Board of Medical Genetics and Genomics Clinical Genetics
Publications & Presentations
PubMed
- 37 citationsAAV capsid prioritization in normal and steatotic human livers maintained by machine perfusion.Jae-Jun Kim, Simone N T Kurial, Pervinder K Choksi, Miguel Nunez, Tyler Lunow-Luke
Nature Biotechnology. 2025-12-01 - Long-term combination therapy with metformin and oxymetholone in a Fanconi anemia mouse model.Craig Dorrell, Alexander M Peters, Qingshuo Zhang, Niveditha Balaji, Kevin Baradar
Pediatric Blood & Cancer. 2024-08-01 - 1 citationsAAV Capsid Screening for Translational Pig Research Using a Mouse Xenograft Liver Model.Melanie Willimann, Amita Tiyaboonchai, Kei Adachi, Bin Li, Lea Waldburger
Biorxiv. 2024-05-29
Press Mentions
Ambys Medicines Announces Formation of Clinical and Scientific Advisory Boards with Leading Liver Disease and Cell and Gene Therapy ExpertsJune 27th, 2022- Ambys Completes $47 Million Series a Extension to Advance Liver Cell Therapy PlatformDecember 21st, 2021
- Tylenol-Based Gene Therapy Makes Treating Genetic Diseases a ‘Walk in the Park’June 15th, 2021
Grant Support
- Intraductal gene therapy for liver cirrhosis.OREGON HEALTH & SCIENCE UNIVERSITY2026–2029
- In vivo selection of gene modified hepatocytesOREGON HEALTH & SCIENCE UNIVERSITY2021–2025
- Gene Therapy for DiabetesOREGON HEALTH & SCIENCE UNIVERSITY2019–2025